Back

Stellate ganglion blockade for treatment of ventricular arrhythmia storm: A meta-analysis

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Interventional treatment for ventricular tachycardia in structural heart disease: new approaches for better outcome? Treatment ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Stefanos Zafeiropoulos

University Hospital Zurich, Zurich (Switzerland)

3 More presentations in this session

Presentation thumbnail
Post-infarct VT substrate ablation based on evoked delayed potential elimination as well-defined target: results from a prospective multicenter study.
Doctor M. De Riva Silva (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Anatomical-based percutaneous left stellate ganglion block in patients with refractory electrical storm: efficacy and safety.
Doctor S. Compagnoni (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Long-term toxicity of radiosurgery for ablation of ventricular tachycardia
Mr J. Cvek (Ostrava, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
Interventional treatment for ventricular tachycardia in structural heart disease: new approaches for better outcome?

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
The quiet after the storm: a case of percutaneous stellate ganglion blockade after acute coronary syndrome
thumbnail
Congress Presentation
Effects of percutaneous left stellate ganglion block on heart rate variability in patient with electrical storm after myocardial infarction.
thumbnail
Congress Presentation
Percutaneous stellate ganglion blockade as an add-on therapy for the treatment of arrhythmic storm

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources